FDA Inspection 1255709 — Medac Gesellschaft fur klinische Spezialpraparate M.B.H.
The FDA completed an inspection of Medac Gesellschaft fur klinische Spezialpraparate M.B.H. on May 9, 2023 in Wedel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 9, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wedel (Germany)
Additional Details
Mutual Recognition Agreement (MRA)